Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Ruoff

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The American Journal of Sports Medicine|February 16, 2006
The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trialEvan F Ekman, Gary Ruoff, Kerry Kuehl, et al.
Current Medical Research and Opinion|July 28, 2006
Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headacheRobert Kaniecki, Gary Ruoff, Timothy Smith, et al.
Headache|September 24, 2005
Valdecoxib for treatment of a single, acute, moderate to severe migraine headacheDavid Kudrow, H Mikel Thomas, Gary Ruoff, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The American Journal of Sports Medicine|February 16, 2006
The COX-2 specific inhibitor Valdecoxib versus tramadol in acute ankle sprain: a multicenter randomized, controlled trialEvan F Ekman, Gary Ruoff, Kerry Kuehl, et al.
Current Medical Research and Opinion|July 28, 2006
Prevalence of migraine and response to sumatriptan in patients self-reporting tension/stress headacheRobert Kaniecki, Gary Ruoff, Timothy Smith, et al.
Headache|September 24, 2005
Valdecoxib for treatment of a single, acute, moderate to severe migraine headacheDavid Kudrow, H Mikel Thomas, Gary Ruoff, et al.
Pageof 2